| scholarly article | Q13442814 |
| P356 | DOI | 10.3345/KJP.2013.56.10.424 |
| P8608 | Fatcat ID | release_a3t3g2vugfht3itb2wsbdk7p7m |
| P932 | PMC publication ID | 3827490 |
| P698 | PubMed publication ID | 24244210 |
| P5875 | ResearchGate publication ID | 258639270 |
| P2093 | author name string | Youn-Soo Hahn | |
| P2860 | cites work | The L-arginine-nitric oxide pathway | Q24304874 |
| Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial | Q24655820 | ||
| Exhaled nitric oxide measurements: clinical application and interpretation | Q24678480 | ||
| Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath | Q24678621 | ||
| Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma | Q24678771 | ||
| Allergen exposure modifies the relation of sensitization to fraction of exhaled nitric oxide levels in children at risk for allergy and asthma | Q30502496 | ||
| Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. | Q31941303 | ||
| Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study | Q33931447 | ||
| Monitoring the patient with asthma: an evidence-based approach. | Q33962522 | ||
| Exhaled markers of pulmonary disease | Q34279117 | ||
| Increased amount of nitric oxide in exhaled air of asthmatics. | Q34290955 | ||
| ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
| Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
| Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years | Q34424366 | ||
| The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 | ||
| Exhaled nitric oxide in childhood asthma: a review | Q34724840 | ||
| An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications | Q35534747 | ||
| Exhaled nitric oxide correlates with airway eosinophils in childhood asthma | Q35535115 | ||
| Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 | ||
| Nitric oxide in health and disease of the respiratory system | Q35842979 | ||
| Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma | Q36266907 | ||
| Nitric oxide in upper airways inflammatory diseases | Q36790693 | ||
| Assessment of asthma control and its impact on optimal treatment strategy | Q36825049 | ||
| The influence of living near roadways on spirometry and exhaled nitric oxide in elementary schoolchildren. | Q36940891 | ||
| Role of GATA-3 in allergic diseases | Q37239744 | ||
| The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? | Q37588020 | ||
| The biology of nitrogen oxides in the airways | Q40386353 | ||
| Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells. | Q40491935 | ||
| Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis | Q40764411 | ||
| Role of nasal nitric oxide in the resolution of experimental rhinovirus infection | Q43538398 | ||
| FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. | Q43545273 | ||
| Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
| Time-dependent effect of nitrate-rich meals on exhaled nitric oxide in healthy subjects | Q43679603 | ||
| Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. | Q43681848 | ||
| Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children | Q43749940 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide | Q44610625 | ||
| Regulation of the expression of inducible nitric oxide synthase | Q45089049 | ||
| Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids | Q46418165 | ||
| Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial | Q46565002 | ||
| Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation | Q46694118 | ||
| Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge | Q46970718 | ||
| Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values | Q47337218 | ||
| Exhaled nitric oxide levels in school children in relation to IgE sensitisation and window pane condensation | Q47781579 | ||
| Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 | ||
| Portable exhaled nitric oxide measurement: Comparison with the "gold standard" technique. | Q51066242 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. | Q51680181 | ||
| Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. | Q51713519 | ||
| A community study of exhaled nitric oxide in healthy children. | Q52228414 | ||
| Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. | Q53344190 | ||
| Increase of exhaled nitric oxide in children exposed to low levels of ambient ozone | Q57116753 | ||
| NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast | Q57638323 | ||
| Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide | Q58387555 | ||
| Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic Asthma | Q61885603 | ||
| A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation | Q73076822 | ||
| Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey | Q73896105 | ||
| Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma | Q74363456 | ||
| Reference values of exhaled nitric oxide for healthy children 6-15 years old | Q74451881 | ||
| The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control | Q74493889 | ||
| Exhaled nitric oxide discriminates children with and without allergic sensitization in a population-based study | Q83454777 | ||
| Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma | Q83992955 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 424-430 | |
| P577 | publication date | 2013-10-31 | |
| P1433 | published in | Korean journal of pediatrics | Q26853872 |
| P1476 | title | Measurements of fractional exhaled nitric oxide in pediatric asthma | |
| P478 | volume | 56 |
Search more.